MARKET

ALZN

ALZN

Alzamend Neuro Inc
NASDAQ
2.040
-0.050
-2.39%
After Hours: 2.078 +0.038 +1.87% 16:52 03/13 EDT
OPEN
2.060
PREV CLOSE
2.090
HIGH
2.116
LOW
2.020
VOLUME
58.43K
TURNOVER
--
52 WEEK HIGH
10.17
52 WEEK LOW
1.580
MARKET CAP
7.76M
P/E (TTM)
-0.3575
1D
5D
1M
3M
1Y
5Y
1D
Alzamend Neuro Q3 net loss widens 112% to USD 2.2 million
Reuters · 3d ago
Weekly Report: what happened at ALZN last week (0302-0306)?
Weekly Report · 6d ago
Alzamend Neuro Establishes ATM Equity Offering Agreement
TipRanks · 03/06 22:16
Alzamend Neuro Enters ATM Sales Agreement To Sell Up To $3.0M In Common Stock
Benzinga · 03/06 21:48
ALZAMEND NEURO INC - ENTERS ATM SALES AGREEMENT TO SELL UP TO $3.0 MLN IN COMMON STOCK - SEC FILING
Reuters · 03/06 21:44
10 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 03/02 12:05
Weekly Report: what happened at ALZN last week (0223-0227)?
Weekly Report · 03/02 09:58
Weekly Report: what happened at ALZN last week (0216-0220)?
Weekly Report · 02/23 09:58
More
About ALZN
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel products for the treatment of Alzheimer's disease (Alzheimer's), bipolar disorder (BD), major depressive disorder (MDD) and post-traumatic stress disorder (PTSD). The Company's pipeline consists of two novel therapeutic drug candidates: AL001, and ALZN002. AL001 is a patented ionic cocrystal technology delivering a therapeutic combination of lithium, salicylate and L-proline through three royalty-bearing exclusive worldwide licenses from the University of South Florida Research Foundation, Inc., (the Licensor). AL001 is used for Alzheimer's, BD, MDD and PTSD treatment. ALZN002 is a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer's by removing beta-amyloid from the brain through a royalty-bearing exclusive worldwide license from the Licensor.

Webull offers Alzamend Neuro Inc stock information, including NASDAQ: ALZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALZN stock methods without spending real money on the virtual paper trading platform.